Business Context and Reporting Period
Company: PLBY Group, Inc. (Playboy, Inc.)
Filing Type: Form 8-K (Current Report)
Date of Report: June 27, 2024
Event: Notice of Delisting or Failure to Satisfy a Continued Listing Rule (Item 3.01)
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The report focuses exclusively on stock listing compliance.
Material Changes
The Company received a Nasdaq Staff Deficiency Letter indicating that for the prior 32 consecutive business days, the bid price for its common stock closed below the minimum $1.00 per share requirement under Nasdaq Listing Rule 5450(a)(1).
Guidance, Outlook, and Risks
- Compliance Period: The Company has an initial 180 calendar days (until December 24, 2024) to regain compliance.
- Compliance Criteria: The stock must close at $1.00 per share or more for a minimum of 10 consecutive business days before the deadline.
- Immediate Impact: The deficiency letter has no immediate effect on the listing or trading of the common stock.
- Future Options: If compliance is not met by December 24, 2024, the Company may apply for an additional 180-day period by transferring to The Nasdaq Capital Market, subject to meeting other listing standards (e.g., market value of publicly held shares).
- Remedial Actions: The Company may consider a reverse stock split to cure the deficiency.
- Risks: There is no assurance the Company will be eligible for an additional compliance period or that Nasdaq will grant continued listing if a delisting notification is issued.
Investor Verification Checklist
- Monitor the daily closing bid price of PLBY stock to track progress toward the $1.00 threshold.
- Verify if the Company announces a reverse stock split or other capital structure changes before December 24, 2024.
- Check for any subsequent 8-K filings regarding the transfer of listing to The Nasdaq Capital Market.
- Review the Company's market value of publicly held shares to assess eligibility for the Capital Market transfer if the initial cure period fails.